Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 21, Issue 7, Pages 1266-1279
Publisher
Wiley
Online
2016-11-10
DOI
10.1111/jcmm.12999
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional Program
- (2016) C. Y. Yim et al. CANCER RESEARCH
- hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells
- (2016) Xuejuan Gao et al. Scientific Reports
- Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells
- (2015) Kuiqing Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment
- (2015) Alex Kiselyov et al. INTERNATIONAL JOURNAL OF CANCER
- CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
- (2015) Bo Wang et al. JOURNAL OF UROLOGY
- Radiosensitization and downregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K) upon inhibition of mitogen/extracellular signal-regulated kinase (MEK) in malignant melanoma cells
- (2015) Stefan Eder et al. Oncotarget
- Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation
- (2015) Xiaoqin Fan et al. Scientific Reports
- Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation
- (2015) Xu Chen et al. Scientific Reports
- Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells
- (2015) Taiyo Otoshi et al. PLoS One
- Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma
- (2015) Li Ming Zhu et al. Oncotarget
- Accumulated SET protein up-regulates and interacts with hnRNPK, increasing its binding to nucleic acids, the Bcl-xS repression, and cellular proliferation
- (2014) Luciana O. Almeida et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma
- (2014) I-Che Chung et al. BMC CANCER
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression
- (2014) Paola Barboro et al. CANCER LETTERS
- Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression
- (2013) Xinlan Fan et al. BMC CANCER
- hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors
- (2013) Ziwei Xiao et al. CARCINOGENESIS
- PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis
- (2013) Xuehui Hong et al. GUT
- XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection
- (2013) Stephanie B. Hatch et al. INTERNATIONAL JOURNAL OF CANCER
- Heterogeneous Nuclear Ribonucleoprotein K (hnRNP-K) Promotes Tumor Metastasis by Induction of Genes Involved in Extracellular Matrix, Cell Movement, and Angiogenesis
- (2013) Ran Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased expression of DNA repair gene XPF enhances resistance to hydroxycamptothecin in bladder cancer
- (2013) Jie Li et al. MEDICAL SCIENCE MONITOR
- CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response
- (2013) Roland Seiler et al. MODERN PATHOLOGY
- Molecular mechanisms of cisplatin resistance in bladder cancer
- (2012) Ross M Drayton et al. Expert Review of Anticancer Therapy
- Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells
- (2011) Monica Ciarlo et al. INTERNATIONAL JOURNAL OF CANCER
- Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance
- (2011) W Li et al. ONCOGENE
- Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma
- (2010) Huaqing Cui et al. BMC CANCER
- Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues
- (2010) Georgios Boukakis et al. BMC CANCER
- The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells
- (2010) Parvaneh Nikpour et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
- (2010) Svetlana Usanova et al. Molecular Cancer
- A novel XPF −357A>C polymorphism predicts risk and recurrence of bladder cancer
- (2010) M Wang et al. ONCOGENE
- Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer
- (2009) P Barboro et al. BRITISH JOURNAL OF CANCER
- Identification of a Protein, G0S2, That Lacks Bcl-2 Homology Domains and Interacts with and Antagonizes Bcl-2
- (2009) C. Welch et al. CANCER RESEARCH
- Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study
- (2009) S. F. Shariat et al. CLINICAL CANCER RESEARCH
- Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player
- (2009) Roberto Benelli et al. INTERNATIONAL JOURNAL OF CANCER
- Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53
- (2009) Renyuan Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- mRNA Silencing in Human Erythroid Cell Maturation
- (2008) Isabel S. Naarmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy
- (2008) Marcos B. Pinho et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started